{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:54:25Z","timestamp":1776405265664,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate the outcomes of surgical and adjunctive treatments for osteonecrosis of the jaw (ONJ) and to analyze the influence of specific risk factors on postoperative wound healing and recurrence rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed surgically treated ARONJ and ORN patients from 2012 to 2017. Demographics, comorbidities, etiology, treatments, and healing outcomes were analyzed using descriptive statistics and multivariate regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009194 patients met inclusion criteria. The overall postoperative healing rate was 78.4%, with wound healing disturbances occurring in 44% of cases. Healing rates were comparable between entities, with 79.4% in ORN and 77.3% in ARONJ patients achieving complete mucosal healing. Neither classical risk factors (smoking, obesity, diabetes) nor treatment regimens predicted wound healing disturbances (WHD). Risk factors for the development of ONJ were not consistently predictive of postoperative complications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Thorough resection with tension-free closure is central to ARONJ and ORN treatment. Close postoperative monitoring \u2013 especially within the first 100 days \u2013 is crucial, given the high early recurrence rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical relevance<\/jats:title>\n                    <jats:p>The findings underscore the importance of surgical intervention \u2013 particularly complete necrotic bone resection with tension-free wound closure \u2013 as the cornerstone of effective treatment for osteonecrosis of the jaw, irrespective of its origin (ARONJ or ORN). Traditional risk factors did not predict wound-healing complications. Within the limitations of this retrospective study, common adjunctive measures did not appear to influence healing outcomes. Given the high rate of early recurrence, vigilant postoperative follow-up\u2014especially within the first 100 days\u2014is essential for optimal patient management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00784-026-06851-6","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:46:13Z","timestamp":1774669573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postoperative healing and recurrence in osteonecrosis of the jaw: influence of risk factors and surgical approach"],"prefix":"10.1007","volume":"30","author":[{"given":"Jonathan","family":"Mohr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Pippich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Cherdron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jannik","family":"Ketschau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Erben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Kram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Krautkremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Deppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus-Dietrich","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas M.","family":"Ritschl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"6851_CR1","unstructured":"Hentsch S (2020) Pschyrembel Online | Nekrose [Internet]. Pschyrembel Online. [cited 2021 Aug 9]. Available from: https:\/\/www.pschyrembel.de\/Nekrose\/K0F1C"},{"key":"6851_CR2","unstructured":"Regaud C (1922) Sur la n\u00e9crose des os atteints par un processus canc\u00e9reux et trait\u00e9s par les radiations. Journal: Cpmtes remdus des seances de la Societe de Biologie et de ses filiales. 25:427\u2013429"},{"key":"6851_CR3","unstructured":"Regaud C (1922) Sur la sensibilite du tissu osseux normal vis-a-vis des rayons X et gamma et sur la mecanisme de l\u2019osteoradionecrose. 87:629\u2013932"},{"key":"6851_CR4","first-page":"17","volume":"13","author":"T Ziebart","year":"2016","unstructured":"Ziebart T, Heymann; P, Attrodt; A, Neff A (2016) Update Kiefernekrose \u2013 Diagnose, Pathophysiologie und Therapie. Perio Tribune - Austrian Ed 13:17\u201318","journal-title":"Perio Tribune - Austrian Ed"},{"key":"6851_CR5","doi-asserted-by":"crossref","unstructured":"Marx RE (2008) Uncovering the cause of phossy jaw Circa 1858 to 1906: oral and maxillofacial surgery closed case files-case closed. J Oral Maxillofac Surg [Internet]. [cited 2025 May 15];66:2356\u201363. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18940506\/","DOI":"10.1016\/j.joms.2007.11.006"},{"key":"6851_CR6","doi-asserted-by":"crossref","unstructured":"Hellstein JW, Marek CL (2005) Bisphosphonate osteochemonecrosis (bis-phossy jaw): Is this phossy jaw of the 21st century?. J Oral Maxillofacial Surg [Internet]. [cited 2025 May 18];63:682\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15883944\/","DOI":"10.1016\/j.joms.2005.01.010"},{"key":"6851_CR7","doi-asserted-by":"crossref","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic [007\/100OL, #40214]. J Oral Maxillofacial Surg [Internet]. [cited 2025 May 18];61:1115\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12966493\/","DOI":"10.1016\/S0278-2391(03)00720-1"},{"key":"6851_CR8","unstructured":"Kr\u00fcger M, Mhabba-N, KAG (2018) S2k-Leitlinie: Infizierte Osteoradionekrose (IORN) der Kiefer. Deutsche Gesellschaft f\u00fcr Mund-, Kiefer- und Gesichtschirurgie (DGMKG. [cited 2021 Aug 10]. Available from: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/007-046"},{"key":"6851_CR9","unstructured":"Schiegnitz E, Hoefert S, Otto S, Pautke C, Ristow O et al (2018) S3-Leitlinie: Antiresorptiva-assoziierte Kiefernekrosen (AR-ONJ) \u2019. Deutsche Gesellschaft f\u00fcr Mund-, Kiefer- und Gesichtschirurgie (DGMKG). [cited 2021 Aug 9]. Available from: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/007-091"},{"key":"6851_CR10","doi-asserted-by":"crossref","unstructured":"Khan AA, Morrison A, Kendler DL, Rizzoli R, Hanley DA, Felsenberg D et al (2017) Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ. J Clin Densitom [Internet]. [cited 2025 May 18];20:8\u201324. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27956123\/","DOI":"10.1016\/j.jocd.2016.09.005"},{"key":"6851_CR11","doi-asserted-by":"crossref","unstructured":"Hallmer F, Bj\u00f8rnland T, Nicklasson A, Becktor JP, Andersson G (2014) Osteonecrosis of the jaw in patients treated with oral and intravenous bisphosphonates: experience in Sweden. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. [cited 2025 May 18];118:202\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25047929\/","DOI":"10.1016\/j.oooo.2014.05.006"},{"key":"6851_CR12","doi-asserted-by":"crossref","unstructured":"Walter C, Al-Nawas B, Frickhofen N, Gamm H, Beck J, Reinsch L et al (2010) Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients. Head Face Med [Internet]. [cited 2025 May 18];6. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20615236\/","DOI":"10.1186\/1746-160X-6-11"},{"key":"6851_CR13","doi-asserted-by":"crossref","unstructured":"Bonomi M, Nortilli R, Molino A, Sava T, Santo A, Caldara A et al (2010) Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis. Med Oncol [Internet]. [cited 2025 May 18];27:224\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19330470\/","DOI":"10.1007\/s12032-009-9195-y"},{"key":"6851_CR14","doi-asserted-by":"crossref","unstructured":"Fizazi K, Carducci M, Smith M, Dami\u00e3o R, Brown J, Karsh L et al (2011) Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet [Internet]. [cited 2025 May 18];377:813\u201322. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21353695\/","DOI":"10.1016\/S0140-6736(10)62344-6"},{"key":"6851_CR15","doi-asserted-by":"crossref","unstructured":"Stopeck AT, Fizazi K, Body JJ, Brown JE, Carducci M, Diel I et al (2016) Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer. Support Care Cancer [Internet]. [cited 2025 May 18];24:447\u201355. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26335402\/","DOI":"10.1007\/s00520-015-2904-5"},{"key":"6851_CR16","doi-asserted-by":"crossref","unstructured":"Baron R, Ferrari S, Russell RGG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone [Internet]. [cited 2025 May 18];48:677\u201392. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21145999\/","DOI":"10.1016\/j.bone.2010.11.020"},{"key":"6851_CR17","doi-asserted-by":"crossref","unstructured":"Thomas D, Carriere P, Jacobs I (2010) Safety of denosumab in giant-cell tumour of bone. Lancet Oncol [Internet]. [cited 2025 May 18];11:815. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20816372\/","DOI":"10.1016\/S1470-2045(10)70170-4"},{"key":"6851_CR18","doi-asserted-by":"crossref","unstructured":"Schuurhuis JM, Stokman MA, Witjes MJH, Dijkstra PU, Vissink A, Spijkervet FKL (2015) Evidence supporting pre-radiation elimination of oral foci of infection in head and neck cancer patients to prevent oral sequelae. A systematic review. Oral Oncol [Internet]. [cited 2025 May 18];51:212\u201320. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25524386\/","DOI":"10.1016\/j.oraloncology.2014.11.017"},{"key":"6851_CR19","doi-asserted-by":"crossref","unstructured":"Studer G, Bredell M, Studer S, Huber G, Glanzmann C (2016) Risk profile for osteoradionecrosis of the mandible in the IMRT era. Strahlenther Onkol [Internet]. [cited 2025 May 18];192:32\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26265308\/","DOI":"10.1007\/s00066-015-0875-6"},{"key":"6851_CR20","doi-asserted-by":"crossref","unstructured":"Reuther T, Schuster T, Mende U, K\u00fcbler AC (2003) Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients\u2013a report of a thirty year retrospective review. Int J Oral Maxillofac Surg [Internet]. [cited 2025 May 18];32:289\u201395. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12767877\/","DOI":"10.1054\/ijom.2002.0332"},{"key":"6851_CR21","doi-asserted-by":"crossref","unstructured":"Studer G, Gr\u00e4tz KW, Glanzmann C (2004) Osteoradionecrosis of the mandibula in patients treated with different fractionations. Strahlenther Onkol [Internet]. [cited 2025 May 18];180:233\u201340. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15057434\/","DOI":"10.1007\/s00066-004-1171-z"},{"key":"6851_CR22","doi-asserted-by":"crossref","unstructured":"Ristow O, Gerngro\u00df C, Schwaiger M, Hohlweg-Majert B, Ristow M, Koerdt S et al (2014) Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw? J Cancer Res Clin Oncol [Internet]. [cited 2025 May 18];140:487\u201393. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24469255\/","DOI":"10.1007\/s00432-014-1588-4"},{"key":"6851_CR23","doi-asserted-by":"crossref","unstructured":"Sedghizadeh PP, Kumar SKS, Gorur A, Schaudinn C, Shuler CF, Costerton JW (2008) Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg [Internet]. [cited 2025 May 18];66:767\u201375. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18355603\/","DOI":"10.1016\/j.joms.2007.11.035"},{"key":"6851_CR24","doi-asserted-by":"crossref","unstructured":"Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer [Internet]. [cited 2025 May 18];100:1995\u20132025. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15108222\/","DOI":"10.1002\/cncr.20162"},{"key":"6851_CR25","doi-asserted-by":"crossref","unstructured":"Frerich B (2013) Infizierte Osteoradionekrose (IORN). Der MKG-Chirurg. ;6:107\u201312","DOI":"10.1007\/s12285-012-0316-9"},{"key":"6851_CR26","doi-asserted-by":"crossref","unstructured":"Abu-Id MH, A\u00e7il Y, Gottschalk J, Kreusch T (2006) Bisphosphonatassoziierte Osteonekrose des Kiefers. Mund - Kiefer - und Gesichtschirurgie [Internet]. [cited 2025 May 18];10:73\u201381. Available from: https:\/\/www.researchgate.net\/publication\/226480818_Bisphosphonatassoziierte_Osteonekrose_des_Kiefers","DOI":"10.1007\/s10006-005-0670-0"},{"key":"6851_CR27","doi-asserted-by":"crossref","unstructured":"Thumbigere-Math V, Tu L, Huckabay S, Dudek AZ, Lunos S, Basi DL et al (2012) A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates. Am J Clin Oncol [Internet]. [cited 2025 May 18];35:386\u201392. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22561331\/","DOI":"10.1097\/COC.0b013e3182155fcb"},{"key":"6851_CR28","doi-asserted-by":"crossref","unstructured":"Raguse JD, Hossamo J, Tinhofer I, Hoffmeister B, Budach V, Jamil B et al (2016) Patient and treatment-related risk factors for osteoradionecrosis of the jaw in patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. [cited 2025 May 18];121:215\u2013221.e1. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26703417\/","DOI":"10.1016\/j.oooo.2015.10.006"},{"key":"6851_CR29","doi-asserted-by":"crossref","unstructured":"Jadu F, Lee L, Pharoah M, Reece D, Wang L (2007) A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients. Ann Oncol [Internet]. [cited 2025 May 18];18:2015\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17804475\/","DOI":"10.1093\/annonc\/mdm370"},{"key":"6851_CR30","doi-asserted-by":"crossref","unstructured":"Miksad RA, Lai K-C, Dodson TB, Woo S-B, Treister NS, Akinyemi O et al (2011) Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist [Internet]. [cited 2025 May 18];16:121\u201332. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21212433\/","DOI":"10.1634\/theoncologist.2010-0183"},{"key":"6851_CR31","doi-asserted-by":"crossref","unstructured":"Ristow O, R\u00fcckschlo\u00df T, Moratin J, M\u00fcller M, K\u00fchle R, Dominik H et al (2021) Wound closure and alveoplasty after preventive tooth extractions in patients with antiresorptive intake-A randomized pilot trial. Oral Dis [Internet]. [cited 2025 May 15];27:532\u201346. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32875698\/","DOI":"10.1111\/odi.13556"},{"key":"6851_CR32","doi-asserted-by":"crossref","unstructured":"M\u00fccke T, Koerdt S, Jung M, Mitchell DA, Wolff KD, Kesting MR et al (2016) The role of mylohyoid flap in the treatment of bisphosphonate-related osteonecrosis of the jaws. J Craniomaxillofac Surg [Internet]. [cited 2025 May 15];44:369\u201373. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26857755\/","DOI":"10.1016\/j.jcms.2015.12.017"},{"key":"6851_CR33","doi-asserted-by":"crossref","unstructured":"M\u00fccke T, Jung M, Koerdt S, Mitchell DA, Loeffelbein D, Kesting MR (2016) Free flap reconstruction for patients with bisphosphonate related osteonecrosis of the jaws after mandibulectomy. J Craniomaxillofac Surg [Internet]. [cited 2025 May 15];44:142\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26752221\/","DOI":"10.1016\/j.jcms.2015.11.015"},{"key":"6851_CR34","doi-asserted-by":"crossref","unstructured":"Ruan HJ, Li MY, Zhang ZY, Ma HL, He Y (2024) Medication-related osteonecrosis of the jaw: a retrospective single center study of recurrence-related factors after surgical treatment. Clin Oral Investig [Internet]. [cited 2025 May 15];28. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39317736\/","DOI":"10.1007\/s00784-024-05911-z"},{"key":"6851_CR35","doi-asserted-by":"crossref","unstructured":"Straub A, Vollmer A, L\u00e2m TT, Brands RC, Stapf M, Scherf-Clavel O et al (2022) Evaluation of advanced platelet-rich fibrin (PRF) as a bio-carrier for ampicillin\/sulbactam. Clin Oral Investig [Internet]. [cited 2025 May 15];26:7033\u201344. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35941396\/","DOI":"10.1007\/s00784-022-04663-y"},{"key":"6851_CR36","doi-asserted-by":"crossref","unstructured":"Ristow O, R\u00fcckschlo\u00df T, Schnug G, Moratin J, Bleymehl M, Zittel S et al (2023) Comparison of different antibiotic regimes for preventive tooth extractions in patients with antiresorptive intake-a retrospective cohort study. Antibiotics (Basel) [Internet]. [cited 2025 May 15];12. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37370316\/","DOI":"10.3390\/antibiotics12060997"},{"key":"6851_CR37","doi-asserted-by":"crossref","unstructured":"M\u00fccke T, Deppe H, Hein J, Wolff KD, Mitchell DA, Kesting MR et al (2016) Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 years. J Craniomaxillofac Surg [Internet]. [cited 2025 May 15];44:1689\u201393. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27555374\/","DOI":"10.1016\/j.jcms.2016.07.026"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-026-06851-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-026-06851-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-026-06851-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:15:44Z","timestamp":1776402944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-026-06851-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6851"],"URL":"https:\/\/doi.org\/10.1007\/s00784-026-06851-6","relation":{},"ISSN":["1436-3771"],"issn-type":[{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"156"}}